References
- Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: Worldwide incidence and trends. Gastroenterology. 2004; 127(5 Suppl 1): S5–S16.
- Frenette C, Gish R. Targeted systemic therapies for hepatocellular carcinoma: Clinical perspectives, challenges and implications. World J Gastroenterol. 2012; 18(6): 498-506.
- El-Serag HB, Rudolph KL. Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gas-troenterology. 2007; 132(7): 2557-2576.
- Mitchell P, Moyle J. Chemiosmotic hypothesis of oxidative phosphorylation. Nature. 1967; 213(5072): 137-139.
- Brandon M, Baldi P, Wallace DC. Mitochondrial mutations in cancer. Oncogene. 2006; 25(34): 4647-4662.
- Chinnery PF, Samuels DC, Elson J, Turnbull DM. Accumulation of mitochondrial DNA mutations in ageing, cancer, and mitochondrial disease: Is there a common mechanism? Lancet. 2002; 360(9342): 1323-1325.
- Holt IJ, Harding AE, Morgan-Hughes JA. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature. 1988; 331(6158): 717-719.
- Ding Z, Ji J, Chen G, Fang H, Yan S, Shen L, et al. Analysis of mitochondrial DNA mutations in Dloop region in thyroid lesions. Biochim Biophys Acta. 2010; 1800(3): 271-274.
- Chen T, He J, Shen L, Fang H, Nie H, Jin T, et al. The mitochondrial DNA 4,977-bp deletion and its implication in copy number alteration in colorectal cancer. BMC Med Genet. 2011; 12: 8 (https://www.ncbi.nlm.nih.gov/pubmed/21232124).
- Lee HC, Wei YH. Mitochondrial DNA instability and metabolic shift in human cancers. Int J Mol Sci. 2009; 10(2): 674-701.
- Lu J, Sharma LK, Bai Y. Implications of mitochondrial DNA mutations and mitochondrial dysfunction in tumorigenesis. Cell Res. 2009; 19(7): 802-815.
- Kao S, Chao HT, Wei YH. Mitochondrial deoxyribonucleic acid 4977-bp deletion is associated with diminished fertility and motility of human sperm. Biol Reprod. 1995; 52(4): 729-736
- Lee HC, Hsu LS, Yin PH, Lee LM, Chi CW. Heteroplasmic mutation of mitochondrial DNA D-loop and 4977-bp deletion in human cancer cells during mitochondrial DNA depletion. Mitochondrion. 2007; 7(1-2): 157-163.
- Wang E, Wong A, Cortopassi G. The rate of mitochondrial mutagenesis is faster in mice than humans. Mutat Res. 1997; 377(2): 157-166.
- Ye C, Shu XO, Wen W, Pierce L, Courtney R, Gao YT, et al. Quantitative analysis of mitochondrial DNA 4977-bp deletion in sporadic breast cancer and benign breast diseases. Breast Cancer Res Treat. 2008; 108(3): 427-434.
- Tseng LM, Yin PH, Chi CW, Hsu CY, Wu CW, Lee LM, et al. Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer. Genes Chromosomes Cancer. 2006; 45(7): 629-638.
- Macmillan CJ, Shoubridge EA. Mitochondrial DNA depletion: Prevalence in a pediatric population referred for neurologic evaluation. Pediatr Neurol. 1996; 14(3): 203-210.
- Shen J, Wan J, Song R, Zhao H. Peripheral blood mitochondrial DNA copy number, length heteroplasmy, and breast cancer risk: A replication study. Carcinogenesis. 2015; 36(11): 1307-1313.
- Mambo E, Chatterjee A, Xing M, Tallini G, Haugen BR, Yeung SC, et al. D. Tumor-specific changes in mtDNA content in human cancer. Int J Cancer. 2005; 116(6): 920-924.
- Laderman KA, Penny JR, Mazzucchelli F, Bresolin N, Scarlato G, Attardi G. Aging-dependent functional alterations of mitochondrial DNA (mtDNA) from human fibroblasts transferred into mtDNA-less cells. J Biol Chem. 1996; 271(27): 15891-15897.
- Agaronyan K, Morozov YI, Anikin M, Temiakov D. Mitochondrial biology. Replication-transcription switch in human mitochondria. Science. 2015; 347(6221): 548-551.
- Copeland WC, Longley MJ. Mitochondrial genome maintenance in health and disease. DNA Repair (Amsterdam). 2014; 19: 190-198 (https://ncbi.nlm.nih.gov/pubmed/24780559).
- Higgs MR, Chouteau P, Lerat H. ‘Liver let die:’ Oxidative DNA damage and hepatotropic viruses. J Gen Virol. 2014; 95(Pt 5): 991-1004.
- Brown DI, Griendling KK. Regulation of signal transduction by reactive oxygen species in the cardiovascular system. Circ Res. 2015; 116(3): 531-549.
- Liou GY, Storz P. Reactive oxygen species in cancer. Free Radic Res. 2010; 44(5): 479-496.
- Fang FC. Antimicrobial actions of reactive oxygen species. MBio. 2011; 2(5): pii: e00141-e00111 (https://www.ncbi.nlm.nih.gov.pubmed/21896680).